(Alliance News) - RedFish LongTerm Capital Spa on Monday announced that it has approved the subscription of a par value capital increase in PureLabs Spa, a company active in clinical diagnostics, for a total of EUR4 million, against a total approved capital increase of EUR15 million.

As of today, considering the subscriptions already completed by the pre-existing shareholders of PureLabs for a total of EUR8.5 million and the additional subscription by RFLTC for EUR4 million, the total capital increase in PureLabs will amount to EUR12.5 million; RFLTC as a result of the above subscription will therefore hold a minority stake of approximately 32%.

In the event of any subsequent full subscription of the capital increase up to the total EUR15 million approved, RFLTC will instead hold a minority stake of approximately 26% in PureLabs.

RFLTC will carry out the subscription transaction through use of its own cash and cash equivalents, amounting to approximately EUR12 million.

PureLabs was founded in December 2022 by Nino Lo Iacono and engages in the acquisition, management, and integration of clinical diagnostic centers, with the dual objective of, first, creating an articulated platform capable of generating economies of scale, synergies, and value and, second, realizing proceeds through a mechanism of sale of the investment to strategic or financial operators, or on the market.

RedFish is 5.1 percent in the red at EUR1.20 per share.

By Claudia Cavaliere, Alliance News reporter

Comments and questions to redazione@alliancenews.com

Copyright 2023 Alliance News IS Italian Service Ltd. All rights reserved.